Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia

Other illness

• general contraindications (acute inflammatory and febrile diseases, venous thrombosis, unstable arterial hypertension, early condition after contrast computed tomography, early condition after lumbar puncture, general serious condition of the patient);
• unstable or untreated epilepsy, based on EEG;
• exacerbation of the main disease (acute psychosis, severe anxiety, tendency to active aggression, etc.);
• active cancer disease;
• diseases of the nervous system (neuropathies, stroke, damage to the cerebellum, labyrinth, Parkinson's disease) causing altered sensitivity to stimuli;
• diseases and illnesses of the musculoskeletal system that disturb the body's balance and the mobility of the limbs.
• general contraindications (acute inflammatory and febrile diseases, venous thrombosis, unstable arterial hypertension, early condition after contrast computed tomography, early condition after lumbar puncture, general serious condition of the patient);
• unstable or untreated epilepsy, based on EEG;
• exacerbation of the main disease (acute psychosis, severe anxiety, tendency to active aggression, etc.);
• active cancer disease;
• diseases of the nervous system (neuropathies, stroke, damage to the cerebellum, labyrinth, Parkinson's disease) causing altered sensitivity to stimuli; diseases and illnesses of the musculoskeletal system disturbing body balance and limb mobility.
• exacerbation of the main disease (acute psychosis, severe anxiety, tendency to active aggression, etc.);
• mental illnesses other than depression and anxiety disorders;
• psychotic diseases (F20- schizophrenia and other schizophrenic disorders);
• general contraindications (acute inflammatory and febrile diseases, venous thrombosis, unstable arterial hypertension, early condition after contrast computed tomography, early condition after lumbar puncture, general serious condition of the patient);
• unstable or untreated epilepsy, based on EEG;
• active cancer disease;
• diseases of the nervous system (neuropathies, stroke, damage to the cerebellum, labyrinth, Parkinson's disease) causing altered sensitivity to stimuli;
• severe cognitive impairment;
• diseases and illnesses of the musculoskeletal system that disturb the body's balance and the mobility of the limbs.

Other

• lack of consent to participate in the study;
• pregnancy;
• Adults (men) suffering from schizophrenia, N=40
• lack of consent to participate in the study;
• Adults (women) addicted to alcohol, N= 60
• lack of consent to participate in the study;
• pregnancy;
• psychoactive substances other than alcohol;
• diagnosis of autism and ADHD;
• PTSD;
• intellectual disability (diagnosis F70 - F79);

• women and men aged ≥ 18 years,
• consent of the patient or legal guardian to participate in the study,
• schizophrenia clinically confirmed for at least 5 years, with predominance of negative symptoms,
• stable drug therapy (treatment unchanged for at least 3 months)
• ability to understand and follow the therapist's instructions,
• functional ability of everyday life on the Barthel scale below 40 points,
• men aged ≥ 18 years,
• consent of the patient or legal guardian to participate in the study,
• clinically confirmed schizophrenia with predominance of negative symptoms,
• stable drug therapy (treatment unchanged for at least 1 month),
• ability to understand and follow the therapist's instructions,
• functional ability of everyday life on the Barthel scale above 40 points,
• female gender;
• age ≥ 18 years;
• consent of the patient or legal guardian to participate in the study;
• alcohol dependence syndrome (F10.2 according to ICD-10);
• history of depressive and anxiety symptoms;
• ability to understand and follow the therapist's instructions;
• functional ability of everyday life on the Barthel scale above 40 points.

Criteria the registry did not label

• Adults suffering from schizophrenia requiring permanent institutional care, N=40